Insider filing · NAMS
Louis G Lange
Director
profile →
NewAmsterdam Pharma Company N.V.
NAMS · Healthcare · 45 filings in 24 months
ticker →
Louis G Lange sold $1.3M of NewAmsterdam Pharma (NAMS)
Executed Mar 11, disclosed Mar 12, 1 day later.
Value, as filed
$1.3M
44,173 sh × $30.41
Executed
Mar 11
the trade date, as filed
Disclosed
Mar 12
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LLLouis G Lange (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $1.3M of NAMS (44,173 sh × $30.41, as filed), executed Mar 11.
The name
NAMSHealthcare · NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with ca…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Louis G Lange in NAMS
NAMSSALE
NewAmsterdam Pharma Company N.V.
$829K28,186 sh × $29.41
Exec Mar 6
Filed Mar 10 · 5:30 PM ET